PRZOOM - /newswire/ -
Chalfont St.Giles, United Kingdom, 2011/02/18 - GE Healthcare, a unit of General Electric Company (NYSE:GE) announced that on 1 April, Kieran Murphy will be promoted to succeed current Life Sciences President and CEO Peter Ehrenheim who will retire from GE after a transition period on July 31 2011. NYSE: GE
Kieran is currently GE Healthcare’s Head of Global Commercial Operations, Life Sciences.
GE Healthcare President and CEO John Dineen said: “Peter is handing over the Life Sciences business to Kieran in great shape, with record 2010 results, a strong portfolio and ambitious growth plans. We thank Peter for his leadership, his 28-year contribution to the business, and we look forward to a smooth transition into Kieran’s hands.”
“Our Life Sciences business is a key part of GE Healthcare and its strategy. Peter has been instrumental in growing and reshaping it since taking charge in 2006. Kieran’s energy, imagination and commercial focus make him ideally suited to continue driving the business forward,” Dineen said.
Kieran joined GE upon its acquisition of Whatman plc, where he was CEO, in 2008. Since then he has helped grow GE Healthcare’s Life Sciences business, initially as Commercial Leader for EMEA and Asia Growth Markets, and then in his current role. With more than twenty years’ commercial experience in the life sciences sector, Kieran began his pharma career with Janssen Pharmaceutical, a division of J&J. Following this with roles at Mallinckrodt and veterinary medicines business Vericore, Kieran was also served as CEO of Adprotech, Innovata plc and of Novartis’s vaccines division.
Peter Ehrenheim is retiring after a career with the company beginning in 1983 as a mechanical designer in R&D with Pharmacia, which was acquired in 1997 by Amersham International. In 2003 Peter was appointed to the Amersham executive team and upon its acquisition by GE in 2004, he was promoted to Vice President and CEO, Life Sciences.
About GE Healthcare
GE Healthcare (gehealthcare.com) provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.
Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries.
For our latest news, please visit newsroom.gehealthcare.com/.